X-43683602-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001270458.2(MAOA):c.-237A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000928 in 1,184,975 control chromosomes in the GnomAD database, including 1 homozygotes. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001270458.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAOA | NM_000240.4 | c.163A>G | p.Ile55Val | missense_variant | 2/15 | ENST00000338702.4 | NP_000231.1 | |
MAOA | NM_001270458.2 | c.-237A>G | 5_prime_UTR_premature_start_codon_gain_variant | 3/16 | NP_001257387.1 | |||
MAOA | NM_001270458.2 | c.-237A>G | 5_prime_UTR_variant | 3/16 | NP_001257387.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111463Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33645
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183115Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67675
GnomAD4 exome AF: 0.00000838 AC: 9AN: 1073512Hom.: 1 Cov.: 26 AF XY: 0.00000293 AC XY: 1AN XY: 340726
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111463Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33645
ClinVar
Submissions by phenotype
Brunner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MAOA protein function. This variant has not been reported in the literature in individuals affected with MAOA-related conditions. This variant is present in population databases (rs747281025, gnomAD 0.008%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 55 of the MAOA protein (p.Ile55Val). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at